Your browser doesn't support javascript.
loading
The scaffold protein p62 regulates adaptive thermogenesis through ATF2 nuclear target activation.
Fischer, Katrin; Fenzl, Anna; Liu, Dianxin; Dyar, Kenneth A; Kleinert, Maximilian; Brielmeier, Markus; Clemmensen, Christoffer; Fedl, Anna; Finan, Brian; Gessner, Andre; Jastroch, Martin; Huang, Jianfeng; Keipert, Susanne; Klingenspor, Martin; Brüning, Jens C; Kneilling, Manfred; Maier, Florian C; Othman, Ahmed E; Pichler, Bernd J; Pramme-Steinwachs, Ines; Sachs, Stephan; Scheideler, Angelika; Thaiss, Wolfgang M; Uhlenhaut, Henriette; Ussar, Siegfried; Woods, Stephen C; Zorn, Julia; Stemmer, Kerstin; Collins, Sheila; Diaz-Meco, Maria; Moscat, Jorge; Tschöp, Matthias H; Müller, Timo D.
Afiliação
  • Fischer K; Institute for Diabetes and Obesity, Helmholtz Diabetes Center (HDC), Helmholtz Zentrum München and German National Diabetes Center (DZD), 85764, Neuherberg, Germany.
  • Fenzl A; Institute for Diabetes and Obesity, Helmholtz Diabetes Center (HDC), Helmholtz Zentrum München and German National Diabetes Center (DZD), 85764, Neuherberg, Germany.
  • Liu D; Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.
  • Dyar KA; Institute for Diabetes and Obesity, Helmholtz Diabetes Center (HDC), Helmholtz Zentrum München and German National Diabetes Center (DZD), 85764, Neuherberg, Germany.
  • Kleinert M; Institute for Diabetes and Obesity, Helmholtz Diabetes Center (HDC), Helmholtz Zentrum München and German National Diabetes Center (DZD), 85764, Neuherberg, Germany.
  • Brielmeier M; Division of Metabolic Diseases, Department of Medicine, Technische Universität München, 80333, Munich, Germany.
  • Clemmensen C; Section of Molecular Physiology, Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, 2200, Copenhagen, Denmark.
  • Fedl A; Research Unit Comparative Medicine, Helmholtz Zentrum München, German Research Center for Environmental Health GmbH, Neuherberg, Germany.
  • Finan B; Institute for Diabetes and Obesity, Helmholtz Diabetes Center (HDC), Helmholtz Zentrum München and German National Diabetes Center (DZD), 85764, Neuherberg, Germany.
  • Gessner A; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200, Copenhagen, Denmark.
  • Jastroch M; Institute for Diabetes and Obesity, Helmholtz Diabetes Center (HDC), Helmholtz Zentrum München and German National Diabetes Center (DZD), 85764, Neuherberg, Germany.
  • Huang J; Institute for Diabetes and Obesity, Helmholtz Diabetes Center (HDC), Helmholtz Zentrum München and German National Diabetes Center (DZD), 85764, Neuherberg, Germany.
  • Keipert S; Novo Nordisk Research Center, Indianapolis, IN, 46241, USA.
  • Klingenspor M; Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Neuherberg, Germany.
  • Brüning JC; Institute for Diabetes and Obesity, Helmholtz Diabetes Center (HDC), Helmholtz Zentrum München and German National Diabetes Center (DZD), 85764, Neuherberg, Germany.
  • Kneilling M; Department of Molecular Biosciences, The Wenner-Gren Institute, The Arrhenius Laboratories F3, Stockholm University, SE-106 91, Stockholm, Sweden.
  • Maier FC; Cancer Metabolism and Signaling Networks Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, 92037, USA.
  • Othman AE; Institute for Diabetes and Obesity, Helmholtz Diabetes Center (HDC), Helmholtz Zentrum München and German National Diabetes Center (DZD), 85764, Neuherberg, Germany.
  • Pichler BJ; Department of Molecular Biosciences, The Wenner-Gren Institute, The Arrhenius Laboratories F3, Stockholm University, SE-106 91, Stockholm, Sweden.
  • Pramme-Steinwachs I; Chair of Molecular Nutritional Medicine, Technical University of Munich, TUM School of Life Sciences Weihenstephan, Gregor-Mendel-Strasse 2, D-85354, Freising, Germany.
  • Sachs S; EKFZ-Else-Kröner Fresenius Center for Nutritional Medicine, Technical University of Munich, Gregor-Mendel-Strasse 2, D-85354, Freising, Germany.
  • Scheideler A; Department of Neuronal Control of Metabolism, Max Planck Institute for Metabolism Research, Gleueler Strasse 50, 50931, Cologne, Germany.
  • Thaiss WM; Policlinic for Endocrinology, Diabetes and Preventive Medicine (PEDP), University Hospital Cologne, Kerpener Strasse 26, 50924, Cologne, Germany.
  • Uhlenhaut H; Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) and Center for Molecular Medicine Cologne (CMMC), University of Cologne, Joseph-Stelzmann-Strasse 26, 50931, Cologne, Germany.
  • Ussar S; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Tübingen, Germany.
  • Woods SC; Department of Dermatology, Eberhard Karls University Tübingen, 72076, Tübingen, Germany.
  • Zorn J; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Tübingen, Germany.
  • Stemmer K; Department of Diagnostic and Interventional Radiology, Eberhard Karls University Hospital Tübingen, Hoppe-Seyler-Straße 3, 72076, Tübingen, Germany.
  • Collins S; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Tübingen, Germany.
  • Diaz-Meco M; Institute for Diabetes and Obesity, Helmholtz Diabetes Center (HDC), Helmholtz Zentrum München and German National Diabetes Center (DZD), 85764, Neuherberg, Germany.
  • Moscat J; Institute for Diabetes and Obesity, Helmholtz Diabetes Center (HDC), Helmholtz Zentrum München and German National Diabetes Center (DZD), 85764, Neuherberg, Germany.
  • Tschöp MH; Research Unit Comparative Medicine, Helmholtz Zentrum München, German Research Center for Environmental Health GmbH, Neuherberg, Germany.
  • Müller TD; Werner Siemens Imaging Center, Department of Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tübingen, Tübingen, Germany.
Nat Commun ; 11(1): 2306, 2020 05 08.
Article em En | MEDLINE | ID: mdl-32385399
ABSTRACT
During ß-adrenergic stimulation of brown adipose tissue (BAT), p38 phosphorylates the activating transcription factor 2 (ATF2) which then translocates to the nucleus to activate the expression of Ucp1 and Pgc-1α. The mechanisms underlying ATF2 target activation are unknown. Here we demonstrate that p62 (Sqstm1) binds to ATF2 to orchestrate activation of the Ucp1 enhancer and Pgc-1α promoter. P62Δ69-251 mice show reduced expression of Ucp1 and Pgc-1α with impaired ATF2 genomic binding. Modulation of Ucp1 and Pgc-1α expression through p62 regulation of ATF2 signaling is demonstrated in vitro and in vivo in p62Δ69-251 mice, global p62-/- and Ucp1-Cre p62flx/flx mice. BAT dysfunction resulting from p62 deficiency is manifest after birth and obesity subsequently develops despite normal food intake, intestinal nutrient absorption and locomotor activity. In summary, our data identify p62 as a master regulator of BAT function in that it controls the Ucp1 pathway through regulation of ATF2 genomic binding.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Quinases p38 Ativadas por Mitógeno / Fator 2 Ativador da Transcrição / Proteína Sequestossoma-1 Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Quinases p38 Ativadas por Mitógeno / Fator 2 Ativador da Transcrição / Proteína Sequestossoma-1 Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha